A regulatory loophole allows businesses to offer potentially ineffective or harmful treatments, a researcher warns
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.